Nutex Health
NUTX
47 hedge funds and large institutions have $7.07M invested in Nutex Health in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 9 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 6
11% more capital invested
Capital invested by funds: $6.39M → $7.07M (+$684K)
0.03% more ownership
Funds ownership: 0.04% → 0.07% (+0.03%)
4% less funds holding
Funds holding: 49 → 47 (-2)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
+$4.51M |
| 2 |
OPOWM
One Plus One Wealth Management
Jupiter,
Florida
|
+$677K |
| 3 |
SWM
Scissortail Wealth Management
Tulsa,
Oklahoma
|
+$146K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$84.2K |
| 5 |
WIA
World Investment Advisors
Santa Barbara,
California
|
+$60.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$247K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$91K |
| 3 |
Renaissance Technologies
New York
|
-$42.2K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$23.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20.5K |
NUTX Hedge Fund Activity: Q1 2024 in Review
47 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Nutex Health (NUTX) for Q1 2024, worth a combined $7.07M — up 11% from $6.39M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of NUTX and 8 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 16 added.
The largest buyer was Highbridge Capital Management, opening a new position worth an estimated $4.51M. The largest seller was MAI Capital Management, cutting an estimated $247K.
- 47 institutional investors held Nutex Health (NUTX) as of Q1 2024, down from 49 in Q4 2023.
- Funds reported $7.07M of Nutex Health stock for Q1 2024, up 11% quarter-over-quarter.
- 8 funds opened new Nutex Health positions in Q1 2024 and 9 closed out, a net change of -1 holder.
- The largest Nutex Health buyer in Q1 2024 was Highbridge Capital Management, an estimated $4.51M added.
- The largest Nutex Health seller in Q1 2024 was MAI Capital Management, an estimated $247K sold.
Based on aggregated 13F filings for Q1 2024.